Related Experiment Videos
Latent sensitization to apomorphine following repeated low doses
B A Mattingly1, J E Gotsick, K Salamanca
1Morehead State University, Department of Psychology, Kentucky 40351.
Behavioral Neuroscience
|August 1, 1988
Summary
Repeated apomorphine injections in rats show dose-dependent sensitization, increasing locomotor activity. Lower doses did not induce sensitization, but prior low-dose treatment enhanced responses to higher doses.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Apomorphine, a dopamine agonist, is used to study neurochemical mechanisms.
- Understanding drug-induced sensitization is crucial for treating substance use disorders and neurological conditions.
- Previous research suggests dopamine agonists can induce behavioral sensitization.
Purpose of the Study:
- To investigate the effects of repeated apomorphine administration on rat locomotor activity.
- To determine if dose and frequency of apomorphine influence sensitization.
- To explore the relationship between prior apomorphine exposure and subsequent responses.
Main Methods:
- Two experiments involving repeated injections of apomorphine (0.2, 1.0, 5.0 mg/kg) or vehicle in rats.
- Locomotor activity was measured in photocell arenas at 24 or 72-hour intervals.
- A final challenge dose of apomorphine was administered after repeated treatments.
Main Results:
- Sensitization, a progressive increase in locomotor activity, was observed with 1.0 and 5.0 mg/kg apomorphine doses.
- A low dose (0.2 mg/kg) of apomorphine caused slight inhibition without sensitization.
- Prior exposure to low-dose apomorphine potentiated the response to a high dose.
- Vehicle injections did not alter activity levels, and chronic apomorphine pretreatment did not affect vehicle response.
Conclusions:
- Apomorphine-induced sensitization is a graded phenomenon dependent on the administered dose.
- The findings challenge autoreceptor tolerance and conditioning as sole explanations for dopamine agonist sensitization.
- Dose-dependent effects and cross-sensitization warrant further investigation in dopaminergic drug research.